Head-To-Head Analysis: Vicarious Surgical (NYSE:RBOT) vs. Autonomix Medical (NASDAQ:AMIX)

Vicarious Surgical (NYSE:RBOT) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, dividends and valuation.

Profitability

This table compares Vicarious Surgical and Autonomix Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vicarious Surgical	N/A	-184.13%	-112.50%
Autonomix Medical	N/A	-228.82%	-186.65%

Volatility & Risk

Vicarious Surgical has a beta of 1.49, suggesting that its share price is 49% more volatile than the S&P 500. Comparatively, Autonomix Medical has a beta of -1.82, suggesting that its share price is 282% less volatile than the S&P 500.

Insider and Institutional Ownership

47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 9.5% of Vicarious Surgical shares are held by insiders. Comparatively, 6.2% of Autonomix Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Vicarious Surgical and Autonomix Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vicarious Surgical	N/A	N/A	-$63.22 million	($6.69)	-0.13
Autonomix Medical	N/A	N/A	-$11.41 million	($3.55)	-0.11

Vicarious Surgical is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Vicarious Surgical and Autonomix Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vicarious Surgical	1	2	0	0	1.67
Autonomix Medical	1	1	1	0	2.00

Vicarious Surgical currently has a consensus price target of $7.00, suggesting a potential upside of 677.78%. Autonomix Medical has a consensus price target of $2.00, suggesting a potential upside of 400.00%. Given Vicarious Surgical’s higher probable upside, equities analysts clearly believe Vicarious Surgical is more favorable than Autonomix Medical.

Summary

Vicarious Surgical beats Autonomix Medical on 7 of the 11 factors compared between the two stocks.

About Vicarious Surgical

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.